Chaoran Wang

1.0k total citations
37 papers, 698 citations indexed

About

Chaoran Wang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Chaoran Wang has authored 37 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Epidemiology. Recurrent topics in Chaoran Wang's work include Analytical Chemistry and Chromatography (3 papers), Natural product bioactivities and synthesis (3 papers) and Chromatography in Natural Products (3 papers). Chaoran Wang is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Natural product bioactivities and synthesis (3 papers) and Chromatography in Natural Products (3 papers). Chaoran Wang collaborates with scholars based in China, United States and Sweden. Chaoran Wang's co-authors include Min Yu, Gustaf Olsson, Honggang Fan, Xiujing Feng, Manyu Song, Tianyuan Yang, Yujie Yao, Yi Liu, Chunyan Wang and Yuan Zhao and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Journal of Agricultural and Food Chemistry.

In The Last Decade

Chaoran Wang

33 papers receiving 689 citations

Peers

Chaoran Wang
Rong Zhao China
Guochun He United States
Marielle Delnomdedieu United States
Guibao Li China
Rong Zhao China
Chaoran Wang
Citations per year, relative to Chaoran Wang Chaoran Wang (= 1×) peers Rong Zhao

Countries citing papers authored by Chaoran Wang

Since Specialization
Citations

This map shows the geographic impact of Chaoran Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaoran Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaoran Wang more than expected).

Fields of papers citing papers by Chaoran Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaoran Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaoran Wang. The network helps show where Chaoran Wang may publish in the future.

Co-authorship network of co-authors of Chaoran Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chaoran Wang. A scholar is included among the top collaborators of Chaoran Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaoran Wang. Chaoran Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Y. H., et al.. (2025). Two years of innovation: A systematic review of empirical generative AI research in language learning and teaching. Computers and Education Artificial Intelligence. 9. 100445–100445. 5 indexed citations
2.
Zhao, Dan, Y.F. Ma, Zhaoyang Li, et al.. (2025). Bioinformatics analysis and development of functional markers for TaMYB4-1A in wheat. PLoS ONE. 20(4). e0319980–e0319980.
3.
Wang, Xiaoya, Chaoran Wang, Yunxi Liu, & Jigang Yang. (2025). False positive of 68Ga-DOTATATE uptake in multiple duodenum and pancreatic metastasis of renal clear cell carcinoma: a case description. Quantitative Imaging in Medicine and Surgery. 15(4). 3687–3691.
4.
Hu, Qing, Yiwen Zhang, Pengcheng Chen, et al.. (2024). Discovery and characterization of naturally occurring covalent inhibitors of SARS-CoV-2 Mpro from the antiviral herb Ephedra. Chinese Journal of Natural Medicines. 22(9). 797–807. 1 indexed citations
5.
Wang, Chaoran, et al.. (2024). Vagus nerve stimulation: a physical therapy with promising potential for central nervous system disorders. Frontiers in Neurology. 15. 1516242–1516242. 2 indexed citations
6.
Wang, Wei, et al.. (2024). Pharmacokinetic and tissue distribution analysis of bioactive compounds from Fuke Qianjin capsules in rats by a validated UPLC MS/MS method. Journal of Pharmaceutical and Biomedical Analysis. 243. 116069–116069. 1 indexed citations
7.
Li, Xiuxiu, et al.. (2024). NovSRC: A Novelty-Oriented Scientific Collaborators Recommendation Model. International Journal of Advanced Computer Science and Applications. 15(3).
8.
Wang, Pan, Tao Hou, Xiaoyu Wang, et al.. (2024). Discovery and characterization of novel ATP citrate lyase inhibitors from Acanthopanax senticosus (Rupr. & Maxim.) Harms. Fitoterapia. 175. 105956–105956.
9.
Kong, Fanming, Chaoran Wang, Jing Zhang, et al.. (2023). Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice. Chinese Herbal Medicines. 15(4). 485–495. 26 indexed citations
10.
Zhang, Yao, Shanqi Guo, Chaoran Wang, et al.. (2022). Acupuncture for prostatectomy incontinence: study protocol for a multicenter single-blind randomized parallel controlled trial. Trials. 23(1). 9–9. 4 indexed citations
11.
Cheng, Wen, Xian Xiao, Yang Liao, et al.. (2022). Conducive target range of breast cancer: Hypoxic tumor microenvironment. Frontiers in Oncology. 12. 978276–978276. 7 indexed citations
12.
Liu, Jia, et al.. (2021). Hydrophilic interaction liquid chromatography for removal of pesticide residues in ginseng extracts. Chinese Journal of Chromatography. 39(4). 444–452. 1 indexed citations
13.
Kong, Fanming, Chaoran Wang, Xiaojiang Li, & Yingjie Jia. (2021). Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis. Frontiers in Pharmacology. 12. 739843–739843. 6 indexed citations
14.
Zhou, Han, Tao Hou, Zhenhua Gao, et al.. (2021). Discovery of eight alkaloids with D1 and D2 antagonist activity in leaves of Nelumbo nucifera Gaertn. Using FLIPR assays. Journal of Ethnopharmacology. 278. 114335–114335. 15 indexed citations
15.
Li, Lu, Dawei Li, Chaoran Wang, et al.. (2019). Aromatic rosane diterpenoids from the roots of Euphorbia ebracteolata and their inhibitory effects against lipase. Bioorganic Chemistry. 94. 103360–103360. 8 indexed citations
16.
Wang, Lien, Yan Zhang, Chaoran Wang, et al.. (2019). A Natural Product with High Affinity to Sigma and 5-HT7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia. Neurochemical Research. 44(11). 2536–2545. 15 indexed citations
17.
Yu, Min, Chaoran Wang, Yi Liu, Gustaf Olsson, & Chunyan Wang. (2017). Sustainability of mega water diversion projects: Experience and lessons from China. The Science of The Total Environment. 619-620. 721–731. 97 indexed citations
18.
Li, Xiaolong, Yanfang Liu, Aijin Shen, et al.. (2014). Efficient purification of active bufadienolides by a class separation method based on hydrophilic solid-phase extraction and reversed-phase high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 97. 54–64. 20 indexed citations
19.
20.
Shi, Shuo, Juan Zhao, Tianming Yao, et al.. (2010). Interaction of [Ru(bpy)2(dppz)]2+ with human telomeric DNA: Preferential binding to G-quadruplexes over i-motif. Biochimie. 92(4). 370–377. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026